查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828089

2025年人工器官和仿生學全球市場報告

Artificial Organ And Bionics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工器官和仿生學市場規模強勁成長，從2024年的328.2億美元增加至2025年的358.6億美元，複合年成長率為9.3%。預測期內的成長歸因於慢性病發病率的上升、醫學創新與研究、移植接受度的提高、政府措施和資金投入以及生物相容性的提高。

預計未來幾年人工器官和仿生市場將快速成長，到2029年將達到561.1億美元，複合年成長率為11.8%。預測期內的成長歸因於醫療保健支出的增加、個人化醫療、簡化的監管支援和核准、3D列印技術的快速發展以及合作研究和夥伴關係。預測期內的主要趨勢包括微型化和穿戴式技術、技術進步、尖端材料的整合、設計中的人工智慧和機器學習，以及3D列印和生物列印技術的進步。

人工器官和仿生學涵蓋旨在取代缺失或缺失的人體器官功能的機器或裝置，而仿生學則涉及建構能夠反映生物體某些特性的人工系統。仿生學的主要目標是延長人類壽命並提升其功能。

該領域的關鍵產品包括人工器官和仿生學。人工器官是用來重建缺失或受損人體器官或身體部位功能的裝置。人工器官分為植入式和體外式，並進一步細分為心臟仿生學和腦仿生學。該領域涵蓋的技術包括機械仿生學和電子仿生學。

2025年春季美國關稅突然上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對影像處理設備、手術用不銹鋼和一次性塑膠等進口零件產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供人工器官和仿生學市場統計數據，包括全球市場規模、區域佔有率、競爭對手的人工器官和仿生學市場佔有率、詳細的人工器官和仿生學細分市場、市場趨勢和商業機會，以及在人工器官和仿生學行業取得成功所需的數據。這份人工器官和仿生學市場研究報告提供了所有必要資訊的完整展望，並詳細分析了該行業的現狀和未來前景。

未來五年的預測成長率為11.8%，較我們先前對該市場的預測略有下降0.1%。下降的主要原因是美國與其他國家之間的關稅影響。美國可能會直接感受到這種影響，因為德國製造的生物相容性膜和瑞士製造的精密微泵的供不應求，這可能會延緩挽救生命的植入手術和仿生肢體的研發。此外，互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響也將對全球經濟和貿易產生更廣泛的負面影響。

預計未來幾年，不斷成長的醫療保健支出將推動人造器官和仿生學市場的成長。醫療保健支出包括醫療保健及相關活動的總支出，例如私人和公共醫療保險、健康研究和公共衛生計劃。醫療保健投資刺激了技術創新，從而開發出更先進、更有效率的人造器官。這包括材料、設計和製造流程的改進。例如，美國聯邦政府機構醫療保險和醫療補助服務中心在2023年12月報告稱，美國國家醫療保健支出將在2022年成長4.3%，高於2021年的2.7%。因此，不斷成長的醫療保健支出正在推動人造器官和仿生學市場的發展。

預計未來移植數量的增加將推動人造器官和仿生學市場的成長。移植是指將組織或器官從捐贈者轉移到接受者，或從身體的一部分轉移到另一部分的外科手術。人造器官是植入體內以取代受損器官並複製其特定功能，使患者能夠過正常生活的裝置。例如，2024 年 1 月，美國器官取得和移植網路 (OPTN) 報告稱，2023 年總合進行了 46,632 例活體和已故捐贈者的器官移植。與 2022 年相比成長了 8.7%，比 2021 年成長了 12.7%，2021 年首次超過 40,000 例。其中，39,679 例移植來自已故捐贈者，比前一年增加 8.9%，連續第 11 年創下紀錄。因此，預計移植數量的增加將顯著推動人工器官和仿生學市場的發展。

來自領先公司的投資正在推動人工器官仿生市場器官移植的轉型。這些投資在推動人工器官發展方面發揮關鍵作用，透過開發功能性、生物相容性的替代品來解決捐贈器官短缺的問題。這不僅為等待器官移植的患者帶來了希望，也有可能改變移植照護的模式。例如，2022年4月，加拿大政府投資200萬美元用於一項創新的器官和組織捐贈計劃，旨在提高加拿大器官捐贈和移植的效率。這筆資金與致力於支持器官捐贈和移植研究的「卓越中心網路」計劃一致。

人工器官和仿生市場的主要企業正在推動助聽器等技術的發展，這些技術可以增強連接性、改善用戶體驗並實現跨各種設備的無縫整合。聽力技術包括旨在幫助殘障人士的設備和解決方案，例如助聽器和人工電子耳。例如，2022 年 11 月，總部位於澳洲的醫療設備公司 Cochlear Limited 的 Nucleus 8 聲音處理器獲得了美國食品藥物管理局(FDA) 的核准。該設備旨在提供方便用戶使用的功能，包括改進的音質、增強的連接性以及與藍牙 LE 音訊技術的兼容性。這項創新允許用戶無線連接到多個設備，例如智慧型手機和電視，以獲得更整合和簡化的聆聽體驗。

2022年12月，美國知名醫療保健產品公司強生公司成功收購了Abiomed，收購金額未揭露。此次策略性收購將使強生公司能夠提供尖端醫療技術，並在全球範圍內推進其醫療科技業務。美國Abiomed公司專注於人工器官和仿生學領域，此次收購對強生公司而言意義重大，旨在進一步加強其在該領域的影響力和創新能力。

人工器官和仿生學市場的主要企業包括 Abiomed Inc.、Asahi Kasei Medical Co., Ltd、Baxter、Berlin Heart GmbH、Boston Scientific Corporation、Cyber​​onics Inc、Getinge、Medtronic PLC、Bornlife Prosthetic and Orthotic Inc、Sonova、LifeNet Health、Terumd、tat. Limited、Advanced Bionics AG、Ottobock SE & Co.KGaA、Second Sight Medical Products Inc.、iWalk Inc.、Jarvik Heart Inc.、St. Jude Medical Inc.、Harmonic Bionics Inc.、Open Bionics、Beta Bionics Inc.、Bionic Prosthetics and Orthotics and Orthoics and Orthoics、Mobius Bulics.

2024年，北美是人工器官和仿生學市場最大的地區。預計亞太地區將成為預測期內人工器官和仿生學全球市場報告中成長最快的地區。這份人工器官和仿生學市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。

人工器官和仿生市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、英國、美國、義大利、西班牙

人工器官仿生市場包括人工心臟、全人工心臟 (TAH)、人工腎臟、人工肝臟、耳部仿生、視覺仿生、整形外科仿生和心臟仿生的銷售。此市場的價值是指“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工器官與仿生學：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球人工器官與仿生市場：成長率分析
  • 全球人工器官與仿生學市場表現：規模與成長，2019-2024
  • 全球人工器官與仿生學市場預測：規模與成長，2024-2029年，2034年
  • 全球人工器官與仿生學：總目標市場（TAM）

第6章 市場細分

  • 全球人工器官和仿生學市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 人造器官
  • 仿生學
  • 全球人工器官和仿生學市場（按固定類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 可植入和外戴
  • 心臟仿生學與腦仿生學
  • 全球人工器官和仿生學市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 機械仿生學
  • 電子仿生學
  • 人工器官與仿生學
  • 全球人工器官和仿生市場：人工器官細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 人工心臟
  • 人工腎
  • 人工肝
  • 人工胰臟
  • 人工肺
  • 全球人工器官與仿生學市場：仿生學細分市場、類型、表現與預測，2019-2024 年、2024-2029 年、2034 年
  • 仿生肢體
  • 仿生眼
  • 外骨骼
  • 神經假體

第7章 區域和國家分析

  • 全球人工器官和仿生學市場：2019-2024 年、2024-2029 年和 2034 年區域表現和預測
  • 全球人工器官及仿生學市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 人工器官與仿生學市場：競爭格局
  • 人工器官和仿生學市場：公司簡介
    • Abiomed Inc.
    • Asahi Kasei Medical Co., Ltd
    • Baxter
    • Berlin Heart GmbH
    • Boston Scientific Corporation

第31章：其他領先和創新企業

  • Cyberonics Inc.
  • Ekso Bionics Holdings Inc.
  • Getinge AB
  • Medtronic PLC
  • Bornlife Prosthetic and Orthotic Inc.
  • Sonova
  • LifeNet Health
  • Terumo Corporation
  • Nano Retina Ltd
  • Edwards Lifesciences Corporation
  • Orthofix Medical Inc
  • Cochlear Limited
  • Advanced Bionics AG
  • Ottobock SE & Co. KGaA
  • Second Sight Medical Products Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年人工器官和仿生學市場：提供新機會的國家
  • 2029年人工器官與仿生市場：細分領域帶來新機會
  • 2029年人工器官與仿生學市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r23939u

Artificial organs and bionics encompass machines or devices designed to substitute the functions of a deficient or absent human organ, while bionics involves constructing artificial systems mirroring certain characteristics of living organisms. Their primary objective is to enhance an individual's lifespan and functionality.

Within this domain, the main products include artificial organs and artificial bionics. Artificial organs are devices utilized to replicate the functions of missing or impaired human organs or body parts. These can be categorized based on fixation types as either implantable or externally-worn, and further segmented into cardiac bionics and brain bionics. The technologies encompassed within this field encompass mechanical bionics and electronic bionics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The artificial organ and bionics market research report is one of a series of new reports from The Business Research Company that provides artificial organ and bionics market statistics, including artificial organ and bionics industry global market size, regional shares, competitors with an artificial organ and bionics market share, detailed artificial organ and bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ and bionics industry. This artificial organ and bionics market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial organ and bionics market size has grown strongly in recent years. It will grow from $32.82 billion in 2024 to $35.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising chronic diseases, medical innovation and research, growing acceptance of transplants, government initiatives and funding, improvements in biocompatibility.

The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $56.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing healthcare expenditure, personalized medicine, regulatory support and streamlined approvals, rapid advancements in 3d printing, collaborations and partnerships. Major trends in the forecast period include miniaturization and wearable technology, technological advancements, advanced materials integration, ai and machine learning in design, 3d printing and bioprinting advancements.

The forecast of 11.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through shortages of German-made biocompatible membranes and Swiss precision micro-pumps, potentially delaying life-saving implant procedures and bionic limb development.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Increasing healthcare expenditure is anticipated to drive the growth of the artificial organ and bionics market in the future. Healthcare expenditure encompasses the total spending on health care and related activities, including both private and public health insurance, health research, and public health initiatives. Investments in healthcare facilitate technological innovations, leading to the development of more advanced and efficient artificial organs. This may involve enhancements in materials, design, and manufacturing processes. For example, in December 2023, the Centers for Medicare and Medicaid Services, a U.S. federal agency, reported that national health expenditures in the United States grew by 4.3% in 2022, up from a 2.7% increase in 2021. Consequently, rising healthcare expenditure is propelling the artificial organ and bionics market forward.

An increasing number of transplants is projected to drive the growth of the artificial organ and bionics market in the future. A transplant involves the surgical procedure where a tissue or organ is transferred from a donor to a recipient, or from one part of the body to another. Artificial organs are devices implanted in the body to replace damaged organs and replicate their specific functions, enabling patients to lead a normal life. For example, in January 2024, the Organ Procurement and Transplantation Network (OPTN), a U.S.-based organization, reported that in 2023, there were a total of 46,632 organ transplants performed using both living and deceased donors. This marked an 8.7% increase compared to 2022 and a 12.7% rise from 2021, the first year to surpass 40,000 transplants. Among these, 39,679 transplants were from deceased donors, reflecting an 8.9% increase from the previous year and setting a record for the eleventh consecutive year. Thus, the growing number of transplants is expected to significantly boost the artificial organ and bionics market.

Major corporate investments are steering the transformation of organ transplantation within the artificial organs and bionics market. These investments play a pivotal role in fostering the development of artificial organs, addressing the scarcity of donor organs by creating functional and biocompatible replacements. This not only offers hope to patients awaiting organ transplants but also holds the potential to revolutionize the landscape of transplantation medicine. An exemplar is the Government of Canada's investment of $2 million in April 2022 towards innovative organ and tissue donation projects, aimed at enhancing organ donation and transplantation efficacy in Canada. This funding aligns with the Networks of Centres of Excellence Program, dedicated to supporting organ donation and transplantation research.

Leading companies in the artificial organ and bionics market are advancing technologies like hearing devices to enhance connectivity, improve user experiences, and enable seamless integration between various devices. Hearing technology includes devices and solutions aimed at assisting individuals with hearing impairments, such as hearing aids and cochlear implants. For example, in November 2022, Cochlear Limited, an Australia-based medical device company, received approval from the U.S. Food and Drug Administration (FDA) for the Nucleus 8 Sound Processor. This device is designed to offer improved sound quality, enhanced connectivity, and user-friendly features, including compatibility with Bluetooth LE Audio technology. This innovation allows users to connect wirelessly to multiple devices, such as smartphones and televisions, creating a more integrated and streamlined listening experience.

In December 2022, Johnson & Johnson, a prominent healthcare products company based in the US, successfully acquired Abiomed Inc. for an undisclosed sum. This strategic acquisition is poised to expedite Johnson & Johnson's progress in providing cutting-edge medical technologies and advancing its MedTech business on a global scale. Abiomed Inc., also based in the US, operates within the sphere of artificial organs and bionics, making its acquisition a significant move for Johnson & Johnson as it aims to further its presence and innovation within this specialized domain.

Major companies operating in the artificial organ and bionics market include Abiomed Inc., Asahi Kasei Medical Co., Ltd, Baxter, Berlin Heart GmbH, Boston Scientific Corporation, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Sonova, LifeNet Health, Terumo Corporation, Nano Retina Ltd, Edwards Lifesciences Corporation, Orthofix Medical Inc, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc, St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd, Phytowelt GreenTechnologies GmbH

North America was the largest region in the artificial organ and bionics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in the artificial organ and bionics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial organ and bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopaedic bionics, and heart bionics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Organ And Bionics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial organ and bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial organ and bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organ and bionics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Artificial Organs; Artificial Bionics
  • 2) By Fixation Type: Implantable And Externally-Worn; Cardiac Bionics And Brain Bionics
  • 3) By Technology: Mechanical Bionics; Electronic Bionics
  • Subsegments:
  • 1) By Artificial Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Pancreas; Artificial Lungs
  • 2) By Artificial Bionics: Bionic Limbs; Bionic Eyes; Exoskeletons; Neural Prosthetics
  • Companies Mentioned: Abiomed Inc.; Asahi Kasei Medical Co., Ltd; Baxter; Berlin Heart GmbH; Boston Scientific Corporation; Cyberonics Inc.; Ekso Bionics Holdings Inc.; Getinge AB; Medtronic PLC; Bornlife Prosthetic and Orthotic Inc.; Sonova; LifeNet Health; Terumo Corporation; Nano Retina Ltd; Edwards Lifesciences Corporation; Orthofix Medical Inc; Cochlear Limited; Advanced Bionics AG; Ottobock SE & Co. KGaA; Second Sight Medical Products Inc.; iWalk Inc.; Jarvik Heart Inc; St. Jude Medical Inc.; Harmonic Bionics Inc.; Open Bionics; Beta Bionics Inc.; Bionic Prosthetics and Orthotics; Mobius Bionics; Touch Bionics Ltd; Phytowelt GreenTechnologies GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Organ And Bionics Market Characteristics

3. Artificial Organ And Bionics Market Trends And Strategies

4. Artificial Organ And Bionics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Organ And Bionics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Organ And Bionics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Organ And Bionics Market Growth Rate Analysis
  • 5.4. Global Artificial Organ And Bionics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Organ And Bionics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Organ And Bionics Total Addressable Market (TAM)

6. Artificial Organ And Bionics Market Segmentation

  • 6.1. Global Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Organs
  • Artificial Bionics
  • 6.2. Global Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable And Externally-Worn
  • Cardiac Bionics And Brain Bionics
  • 6.3. Global Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Bionics
  • Electronic Bionics
  • Artificial Organ And Bionics
  • 6.4. Global Artificial Organ And Bionics Market, Sub-Segmentation Of Artificial Organs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Artificial Heart
  • Artificial Kidney
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Lungs
  • 6.5. Global Artificial Organ And Bionics Market, Sub-Segmentation Of Artificial Bionics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bionic Limbs
  • Bionic Eyes
  • Exoskeletons
  • Neural Prosthetics

7. Artificial Organ And Bionics Market Regional And Country Analysis

  • 7.1. Global Artificial Organ And Bionics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Organ And Bionics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Organ And Bionics Market

  • 8.1. Asia-Pacific Artificial Organ And Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Organ And Bionics Market

  • 9.1. China Artificial Organ And Bionics Market Overview
  • 9.2. China Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Organ And Bionics Market

  • 10.1. India Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Organ And Bionics Market

  • 11.1. Japan Artificial Organ And Bionics Market Overview
  • 11.2. Japan Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Organ And Bionics Market

  • 12.1. Australia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Organ And Bionics Market

  • 13.1. Indonesia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Organ And Bionics Market

  • 14.1. South Korea Artificial Organ And Bionics Market Overview
  • 14.2. South Korea Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Organ And Bionics Market

  • 15.1. Western Europe Artificial Organ And Bionics Market Overview
  • 15.2. Western Europe Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Organ And Bionics Market

  • 16.1. UK Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Organ And Bionics Market

  • 17.1. Germany Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Organ And Bionics Market

  • 18.1. France Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Organ And Bionics Market

  • 19.1. Italy Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Organ And Bionics Market

  • 20.1. Spain Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Organ And Bionics Market

  • 21.1. Eastern Europe Artificial Organ And Bionics Market Overview
  • 21.2. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Organ And Bionics Market

  • 22.1. Russia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Organ And Bionics Market

  • 23.1. North America Artificial Organ And Bionics Market Overview
  • 23.2. North America Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Organ And Bionics Market

  • 24.1. USA Artificial Organ And Bionics Market Overview
  • 24.2. USA Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Organ And Bionics Market

  • 25.1. Canada Artificial Organ And Bionics Market Overview
  • 25.2. Canada Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Organ And Bionics Market

  • 26.1. South America Artificial Organ And Bionics Market Overview
  • 26.2. South America Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Organ And Bionics Market

  • 27.1. Brazil Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Organ And Bionics Market

  • 28.1. Middle East Artificial Organ And Bionics Market Overview
  • 28.2. Middle East Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Organ And Bionics Market

  • 29.1. Africa Artificial Organ And Bionics Market Overview
  • 29.2. Africa Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Organ And Bionics Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Organ And Bionics Market Competitive Landscape
  • 30.2. Artificial Organ And Bionics Market Company Profiles
    • 30.2.1. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Asahi Kasei Medical Co., Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Baxter Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Berlin Heart GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Organ And Bionics Market Other Major And Innovative Companies

  • 31.1. Cyberonics Inc.
  • 31.2. Ekso Bionics Holdings Inc.
  • 31.3. Getinge AB
  • 31.4. Medtronic PLC
  • 31.5. Bornlife Prosthetic and Orthotic Inc.
  • 31.6. Sonova
  • 31.7. LifeNet Health
  • 31.8. Terumo Corporation
  • 31.9. Nano Retina Ltd
  • 31.10. Edwards Lifesciences Corporation
  • 31.11. Orthofix Medical Inc
  • 31.12. Cochlear Limited
  • 31.13. Advanced Bionics AG
  • 31.14. Ottobock SE & Co. KGaA
  • 31.15. Second Sight Medical Products Inc.

32. Global Artificial Organ And Bionics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Organ And Bionics Market

34. Recent Developments In The Artificial Organ And Bionics Market

35. Artificial Organ And Bionics Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Organ And Bionics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Organ And Bionics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Organ And Bionics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer